Scholarly Index
Theresa Hunter
Eli Lilly (United States); 2,058 total citations; 312 total publications; best world rank #107
Eli Lilly (United States)
2,058Total citations
312Total publications
21H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Spondyloarthritis Studies and Treatments | Lifetime | 953 | US 162 | 91.91 |
| Inflammatory Bowel Disease | 2021-2025 | 178 | US 40 | 97.83 |
| Microscopic Colitis | 2021-2025 | 138 | US 42 | 97.67 |
| Eosinophilic Esophagitis | 2021-2025 | 133 | US 57 | 96.81 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 144 | US 26 | 95.57 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 363 | US 60 | 94.72 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 301 | US 65 | 93.01 |
| Pharmacology and Obesity Treatment | 2021-2025 | 107 | US 51 | 91.71 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 675 | US 111 | 86.02 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | 2021-2025 | 619 | US 134 | 83.11 |
| Celiac Disease Research and Management | 2021-2025 | 915 | US 145 | 62.61 |